VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
92,076
AK1,880
AL6,345
AR4,151
AS46
AZ14,991
CA66,887
CO12,550
CT8,943
DC1,795
DE2,009
FL42,724
FM4
GA17,031
GU124
HI2,580
IA4,919
ID2,892
IL22,128
IN24,197
KS5,047
KY9,111
LA5,500
MA15,718
MD13,434
ME3,351
MH8
MI20,971
MN13,585
MO10,747
MP30
MS3,198
MT2,477
NC18,051
ND1,501
NE3,109
NH3,218
NJ20,216
NM4,218
NV4,728
NY37,667
OH20,793
OK6,692
OR9,244
PA25,607
PR2,588
QM2
RI2,163
SC7,261
SD1,282
TN10,445
TX39,890
UT4,618
VA15,980
VI67
VT1,830
WA16,071
WI12,042
WV2,571
WY926
XB5
XL1
XV2

ID: 1568563
Sex: F
Age: 44
State: RI

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Injection site reaction; Warm at injection site; Itchy at the injection site; Redness at injection site; Painful at injection site/tender at injection site; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of INJECTION SITE REACTION (Injection site reaction), INJECTION SITE WARMTH (Warm at injection site), INJECTION SITE PRURITUS (Itchy at the injection site), INJECTION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PAIN (Painful at injection site/tender at injection site) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. No Medical History information was reported. On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Dec-2020, the patient experienced INJECTION SITE REACTION (Injection site reaction), INJECTION SITE WARMTH (Warm at injection site), INJECTION SITE PRURITUS (Itchy at the injection site), INJECTION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PAIN (Painful at injection site/tender at injection site). At the time of the report, INJECTION SITE REACTION (Injection site reaction), INJECTION SITE WARMTH (Warm at injection site), INJECTION SITE PRURITUS (Itchy at the injection site), INJECTION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PAIN (Painful at injection site/tender at injection site) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. A spontaneous case was received from a Pharmacist on 20-JAN-2021 which refers to a Female who developed the following events injection site reaction(PT: Vaccination site reaction ,itchy at injection site(PT: Vaccination site pruritus),redness at injection site(PT: Vaccination site erythema),warm at injection site(PT: Vaccination site warmth) and tender at injection site(PT: Vaccination site tenderness) The patients past medical history and concomitant medications list were not reported. No lab data were reported. The patient received their first of two planned doses of mRNA-1273 (Batch No 011J20A) on 28-DEC-2020, intramuscularly. The outcome of all the events were reported as resolved. The action taken for Moderna COVID-19 Vaccine was Unknown. The medical reviewer may provide a case evaluation statement, including other possible etiological and confounding factors, e.g. (only limited information has been obtained so far, it is difficult to assess the cause and effect relationship; the co-medications y and x should also be considered causative as the reported event is labeled for both drugs; the company's view is the event is not due to the drug for the following reasons ? (probably due to pre- existing disease); there is no plausible mechanism to implicate the drug. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1568564
Sex: F
Age: 58
State: GA

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pounding headache; Itchy entire arm; Injection site red; Injection site was swollen; Inflammation on the injection site; Warm to touch, injection site hot; Discomfort on the injection site; This spontaneous case was reported by a pharmacist and describes the occurrence of INJECTION SITE INFLAMMATION (Inflammation on the injection site), INJECTION SITE WARMTH (Warm to touch, injection site hot), DISCOMFORT (Discomfort on the injection site), INJECTION SITE ERYTHEMA (Injection site red) and INJECTION SITE SWELLING (Injection site was swollen) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Migraine, Lung nodule and Cellulitis. Concurrent medical conditions included Seasonal allergy. Concomitant products included FLUTICASONE PROPIONATE (FLONASE N S), ALBUTEROL SULFATE (ALBUTEROL) and FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Seasonal allergy. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced INJECTION SITE INFLAMMATION (Inflammation on the injection site), INJECTION SITE WARMTH (Warm to touch, injection site hot) and DISCOMFORT (Discomfort on the injection site). On 14-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (Injection site red) and INJECTION SITE SWELLING (Injection site was swollen). On 20-Jan-2021, the patient experienced HEADACHE (Pounding headache) and INJECTION SITE PRURITUS (Itchy entire arm). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency and STEROIDS at an unspecified dose and frequency. At the time of the report, INJECTION SITE INFLAMMATION (Inflammation on the injection site), INJECTION SITE WARMTH (Warm to touch, injection site hot), DISCOMFORT (Discomfort on the injection site), INJECTION SITE ERYTHEMA (Injection site red), INJECTION SITE SWELLING (Injection site was swollen), HEADACHE (Pounding headache) and INJECTION SITE PRURITUS (Itchy entire arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment included hot and cold compress.

Other Meds: FLONASE N S; ALBUTEROL; ALLEGRA

Current Illness:

ID: 1568565
Sex: F
Age: 81
State: TX

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: welts in small patches; itching at arm; arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of Pain in extremity (arm was sore), Urticaria (welts in small patches) and Urticaria (welts in small patches) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No reported medical history). On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 25 milligram. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (COVID 19 Vaccine Moderna) administered intramuscularly, the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter.

Other Meds:

Current Illness:

ID: 1568566
Sex: F
Age: 42
State: CA

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain in arm and leg; Neck pain; Joint pain; Muscle pain; Pain at the injection site in shoulder; Felt uncomfortable; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Pain in arm and leg), MALAISE (Felt uncomfortable), NECK PAIN (Neck pain), VACCINATION SITE PAIN (Pain at the injection site in shoulder) and ARTHRALGIA (Joint pain) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. Concomitant products included DEXKETOPROFEN TROMETAMOL (DEXALGIN) for an unknown indication. On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced MALAISE (Felt uncomfortable) and VACCINATION SITE PAIN (Pain at the injection site in shoulder). On 20-Jan-2021, the patient experienced NECK PAIN (Neck pain), ARTHRALGIA (Joint pain) and MYALGIA (Muscle pain). On 21-Jan-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm and leg). The patient was treated with IBUPROFEN at an unspecified dose and frequency and CANNABIDIOL at an unspecified dose and frequency. On 18-Jan-2021, MALAISE (Felt uncomfortable) outcome was unknown. At the time of the report, PAIN IN EXTREMITY (Pain in arm and leg), NECK PAIN (Neck pain), VACCINATION SITE PAIN (Pain at the injection site in shoulder), ARTHRALGIA (Joint pain) and MYALGIA (Muscle pain) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds: DEXALGIN

Current Illness:

ID: 1568567
Sex: M
Age: 75
State: OH

Vax Date: 01/07/2021
Onset Date: 01/13/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Burning on the center of his back to his down right side of the shoulder; when he stands up feel a hot pain; back is hot at the touch; A spontaneous report was received from a consumer concerning a 75-years-old, male patient who experienced burning on the center of his back to his down right side of the shoulder, back is hot at the touch, pain and when he stands up feel a hot pain. The patient's medical history was not provided. Concomitant product use was not provided by the reporter. On 07 Jan 2021, approximately seven days prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 [Lot number 026L20] intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 13 Jan 2021, the patient started experiencing burning in the center of his back to his down right side shoulder. His shoulder is hot at the touch. Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not provided. The outcome of the events burning on the center of his back to his down right side of the shoulder, back is hot at the touch, pain and when he stands up feel a hot pain was unknown.

Other Meds:

Current Illness:

ID: 1568568
Sex: F
Age:
State:

Vax Date:
Onset Date: 01/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Side effects; injection site itching; injection site pain; injection site swollen; injection site redness; A spontaneous report was received from a consumer concerning a female patient who experienced injection site pain, injection site swollen, injection site redness, injection site itching. The patient's medical history was not provided. Concomitant product use was not provided by the reporter. On 07 Jan 2021, approximately two days prior to the onset of the symptoms, the patient received their planned dose of mRNA-1273 (Batch number not provided) for prophylaxis of COVID-19 infection. On 09 Jan 2021, the patient experienced injection site pain, injection site swollen, injection site redness, injection site itching. Treatment information was not provided. Action taken with mRNA-1273 in response to the event(s) was not provided. The outcome of the events injection site pain, injection site swollen, injection site redness, injection site itching was unknown.

Other Meds:

Current Illness:

ID: 1568569
Sex: M
Age: 73
State: FL

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Went to bathroom and it was all blood/Filled the toilet with blood/Blood in urine; This spontaneous case was reported by a consumer and describes the occurrence of HAEMATURIA (Went to bathroom and it was all blood/Filled the toilet with blood/Blood in urine) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. No Medical History information was reported. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced HAEMATURIA (Went to bathroom and it was all blood/Filled the toilet with blood/Blood in urine). At the time of the report, HAEMATURIA (Went to bathroom and it was all blood/Filled the toilet with blood/Blood in urine) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. No treatment and concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1568570
Sex: F
Age:
State:

Vax Date: 01/11/2021
Onset Date: 01/18/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itchy; Big rash on her arm at the site of the injection; Not terribly painful; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH (Big rash on her arm at the site of the injection) and VACCINATION SITE PAIN (Not terribly painful) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH (Big rash on her arm at the site of the injection) and VACCINATION SITE PAIN (Not terribly painful). At the time of the report, VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH (Big rash on her arm at the site of the injection) and VACCINATION SITE PAIN (Not terribly painful) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1568571
Sex: F
Age:
State:

Vax Date: 01/15/2021
Onset Date: 01/18/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: shooting pain in the left eye; This spontaneous case was reported by a consumer and describes the occurrence of EYE PAIN (shooting pain in the left eye) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2021, the patient experienced EYE PAIN (shooting pain in the left eye). On 18-Jan-2021, EYE PAIN (shooting pain in the left eye) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1568572
Sex: F
Age: 37
State: CA

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy) in a 37-year-old female patient (gravida 3, para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The patient's past medical history included Pregnancy (forceps delivery Live, full -term birth) on 12-Apr-2015 and Pregnancy (no complication Live, full -term birth) on 11-Oct-2018. Concurrent medical conditions included Gestational diabetes. Concomitant products included VITAMIN B6, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]), COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), CALCIUM LEVOMEFOLATE (METHYL FOLATE), CALCIUM and DOCOSAHEXAENOIC ACID (DHA) for an unknown indication. On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 20-Jul-2020 and the estimated date of delivery was 13-Apr-2021. On 01-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the twenty-eighth week of the pregnancy. On 01-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jul-2020, Pregnancy test: positive (Positive) Positive. On 20-Jan-2021, Glucose tolerance test: not provided (Positive) Gestational diabetes confirmed.. On 20-Jan-2021, Ultrasound scan: normal (normal) Normal. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds: VITAMIN B6; PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]; VITAMIN D [COLECALCIFEROL]; METHYL FOLATE; CALCIUM; DHA

Current Illness: Gestational diabetes

ID: 1568573
Sex: M
Age: 91
State:

Vax Date: 01/05/2021
Onset Date: 01/12/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Blisters on left foot and on the bottom of calf; This spontaneous case was reported by an other caregiver and describes the occurrence of BLISTER (Blisters on left foot and on the bottom of calf) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced BLISTER (Blisters on left foot and on the bottom of calf). The patient was treated with CHLORINE DIOXIDE, MENTHA X PIPERITA OIL (OXYFRESH FRESH BREATH FRESH MINT MOUTHWASH) for Blister, at an unspecified dose and frequency. On 14-Jan-2021, BLISTER (Blisters on left foot and on the bottom of calf) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1568574
Sex: F
Age: 49
State: TX

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore arm; could barely lift it up; body ache; very tender; swollen under arm; feels like she's getting the flu; joint pain; tired; Muscle aches; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), DYSKINESIA (could barely lift it up), PAIN (body ache), TENDERNESS (very tender) and PERIPHERAL SWELLING (swollen under arm) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Blood pressure. On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), DYSKINESIA (could barely lift it up), PAIN (body ache), TENDERNESS (very tender), PERIPHERAL SWELLING (swollen under arm), INFLUENZA LIKE ILLNESS (feels like she's getting the flu), ARTHRALGIA (joint pain), FATIGUE (tired), MYALGIA (Muscle aches) and CHILLS (chills). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm), DYSKINESIA (could barely lift it up), PAIN (body ache), TENDERNESS (very tender), PERIPHERAL SWELLING (swollen under arm), INFLUENZA LIKE ILLNESS (feels like she's getting the flu), ARTHRALGIA (joint pain), FATIGUE (tired), MYALGIA (Muscle aches) and CHILLS (chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness: Blood pressure

ID: 1568575
Sex: F
Age:
State: PA

Vax Date:
Onset Date: 02/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: huge lump on her left arm where she got the shot; golf ball size; whole arm is completely numb; tingles; pregnant; arm hurt really bad; This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE MASS (huge lump on her left arm where she got the shot; golf ball size), HYPOAESTHESIA (whole arm is completely numb), PARAESTHESIA (tingles), MATERNAL EXPOSURE DURING PREGNANCY (pregnant) and VACCINATION SITE PAIN (arm hurt really bad) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. Concurrent medical conditions included Pregnancy (No medical history reported.). On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 06-Oct-2021. On 03-Feb-2021, the patient experienced VACCINATION SITE MASS (huge lump on her left arm where she got the shot; golf ball size), HYPOAESTHESIA (whole arm is completely numb), PARAESTHESIA (tingles), MATERNAL EXPOSURE DURING PREGNANCY (pregnant) and VACCINATION SITE PAIN (arm hurt really bad). On 03-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (pregnant) had resolved. At the time of the report, VACCINATION SITE MASS (huge lump on her left arm where she got the shot; golf ball size), HYPOAESTHESIA (whole arm is completely numb), PARAESTHESIA (tingles) and VACCINATION SITE PAIN (arm hurt really bad) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1568576
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnancy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Pregnancy). At the time of the report, EXPOSURE DURING PREGNANCY (Pregnancy) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided. No concomitant medication was provided. Company Comment: This is a case of product exposure during pregnancy with no associated AEs for this female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.

Other Meds:

Current Illness:

ID: 1568577
Sex: M
Age: 66
State:

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of abdominal discomfort, diarrhea, headache, arm pain and body ache in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient was treated with ALUMINIUM HYDROXIDE GEL, DRIED, MAGNESIUM CARBONATE (ANTICID) at an unspecified dose and frequency. On 08 Jan 2021, the patient experienced headache and arm pain. On 11 Jan 2021, the patient experienced diarrhea and abdominal discomfort. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter.

Other Meds:

Current Illness:

ID: 1568578
Sex: F
Age:
State: TN

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: her back felt like it was about to break; her muscles still feel kinda sore; her sinus was messed up; she was feeling really bad; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (her back felt like it was about to break), MYALGIA (her muscles still feel kinda sore), SINUS DISORDER (her sinus was messed up) and FEELING ABNORMAL (she was feeling really bad) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Shingles. Concomitant products included IRON, CYANOCOBALAMIN (B12-VITAMIIN), SPIRONOLACTONE, ROSUVASTATIN CALCIUM (CRESTOR), VITAMIN D [VITAMIN D NOS], ZINC and ASCORBIC ACID (VITAMINE C) for an unknown indication. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced BACK PAIN (her back felt like it was about to break), MYALGIA (her muscles still feel kinda sore), SINUS DISORDER (her sinus was messed up) and FEELING ABNORMAL (she was feeling really bad). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at an unspecified dose and frequency and PSEUDOEPHEDRINE HYDROCHLORIDE (SUDAFED 12 HOUR) at an unspecified dose and frequency. At the time of the report, BACK PAIN (her back felt like it was about to break), MYALGIA (her muscles still feel kinda sore), SINUS DISORDER (her sinus was messed up) and FEELING ABNORMAL (she was feeling really bad) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.

Other Meds: IRON; B12-VITAMIIN; SPIRONOLACTONE; CRESTOR; VITAMIN D [VITAMIN D NOS]; ZINC; VITAMINE C

Current Illness:

ID: 1568579
Sex: F
Age:
State:

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No reported medical history). On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Redness at the injection site) had not resolved. No concomitant meds were provided. No treatment information provided.

Other Meds:

Current Illness:

ID: 1568580
Sex: F
Age:
State: WA

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Circle of inflammation at the injection site; Mild headache; Diarrhea; Lump at injection site; Arm soreness; arm weakness; Instant redness within 15 minutes; itching; Fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Arm soreness), LIMB DISCOMFORT (arm weakness), DIARRHOEA (Diarrhea), INJECTION SITE INFLAMMATION (Circle of inflammation at the injection site) and ERYTHEMA (Instant redness within 15 minutes) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Allergy (Allergies to fillers and bonding agents.). On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness), LIMB DISCOMFORT (arm weakness), ERYTHEMA (Instant redness within 15 minutes), PRURITUS (itching), FATIGUE (Fatigue) and INJECTION SITE INDURATION (Lump at injection site). On 14-Jan-2021, the patient experienced DIARRHOEA (Diarrhea) and HEADACHE (Mild headache). On 21-Jan-2021, the patient experienced INJECTION SITE INFLAMMATION (Circle of inflammation at the injection site). On 15-Jan-2021, HEADACHE (Mild headache) had resolved. On 17-Jan-2021, DIARRHOEA (Diarrhea) had resolved. On 18-Jan-2021, PAIN IN EXTREMITY (Arm soreness) had not resolved, LIMB DISCOMFORT (arm weakness), PRURITUS (itching), FATIGUE (Fatigue) and INJECTION SITE INDURATION (Lump at injection site) had resolved. At the time of the report, INJECTION SITE INFLAMMATION (Circle of inflammation at the injection site) outcome was unknown and ERYTHEMA (Instant redness within 15 minutes) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1568581
Sex: F
Age: 83
State: CT

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: dizzy; A spontaneous report3w2aq was received from a 83-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced dizziness. There is no previous reported medical history of the patient as such. On 18th Jan at 07:00 pm, approximately nine hours after receiving the first dose of mRNA-1273 (Lot number: 012L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection, the patient started feeling dizziness. The feeling was gone at around 03:00 am on 19th Jan, the following morning. Action taken with mRNA-1273 in response to the events was not reported. The event, feeling of dizziness were considered resolved on 19th Jan 2021.

Other Meds:

Current Illness:

ID: 1568582
Sex: F
Age:
State:

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: ache; headache; nausea; tiredness; injection site hot; injection site redness; injection site swell; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and developed injection site hot, injection site redness, injection site swell, headache, ache, nausea and tiredness. The patient's medical history was not provided. No relevant concomitant medications were reported. The patient received their first of two planned doses of mRNA-1273 on 05 Jan 2021 intramuscularly for prophylaxis of COVID-19 infection. The patient received their second of two planned doses of mRNA-1273 on 02 Feb 2021 intramuscularly for prophylaxis of COVID-19 infection. Patient had a question on an adverse effect they had and wanted some information. She mentioned that she took her fist dose on 05 Jan 2021 and experienced injection hot, redness and swell. Second dose was on 02 Feb 2021, she experienced, headache, ache, nausea and tiredness. She mentioned that she followed up with her doctor. No further information provided. No treatment information was provided for events. Action taken with RNA-1273 in response to the event was unknown. The outcome of the events was unknown. The reporter did not provide an assessment for the events, injection site hot, injection site redness, injection site swell, headache, ache, nausea and tiredness.

Other Meds:

Current Illness:

ID: 1568583
Sex: M
Age: 45
State: TN

Vax Date: 12/26/2020
Onset Date: 01/21/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Covid-19; A spontaneous report was received from a consumer concerning a 45- year old-male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced covid-19. The patient's medical history was not provided.No relevant concomitant medications were reported. On 26-Dec-2020,prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch 011J20A) intramuscularly on right arm for prophylaxis of COVID-19 infection. On 21-Jan-2021,the patient tested positive (on pcr but negative on rapid test),he is asymptomatic. Laboratory data included,covid-19 PCR test positive and covid-19 rapid test negative,was provided.Treatment information was not provided. Action taken with mRNA-1273 in response to the events was unknown. The outcome of the event covid-19 was considered as unknown at the time of the report.

Other Meds:

Current Illness:

ID: 1568584
Sex: F
Age: 77
State: TX

Vax Date: 01/09/2021
Onset Date: 01/20/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever around injection Site; Redness 2" around injection site; Case reference number MOD-2021-011252 is a spontaneous case report sent by a Non-Health Professional on 21-JAN-2021 00:00:00 , which refers to a Female aged 77 Years. At the time of the event the patient had Blood pressure. The following drugs are known to have been taken by the patient prior to the event: METOPROLOL and LOSARTAN. On 09-JAN-2021, the patient received Moderna COVID-19 Vaccine in the upper left arm for COVID-19 vaccination. On 20-JAN-2021, the patient developed Injection site redness and and fever around injection Site . The action taken for Moderna COVID-19 Vaccine was Unknown on.The Non-Health Professional did not declare any relatedness between Redness 2 injection site and Moderna COVID-19 Vaccine. The outcome of the event(s) was unknownot reported.

Other Meds: METOPROLOL; LOSARTAN

Current Illness:

ID: 1568585
Sex: F
Age: 41
State: IL

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: extremely cold hands; warm feeling on face; spot grew to about the size of a baseball; warm to touch; red spot at the injection site; painful to touch; mild pain in her left arm; A report was received from a consumer who is patient's husband. The consumer reported that his wife, 41 years old female patient was participating in the mRNA-1273 Emergency Use Program and experienced Pain - Left Arm, Red - At Injection Site, Swelling - At Injection Site, Painful to Touch - At Injection Site, Warm to Touch - At Injection Site, Warm Feeling on Face, Extremely Cold Hands. No relevant concomitant medications were reported. The patient received their first planned dose of mRNA-1273 on 12-JAN-2021 in her Left upper arm. The patient had some mild pain in her Left arm the same day she received the Moderna COVID-19 Vaccine. Also when she woke up on the day of 19-JAN-2021 with a Red Spot at the Injection Site and reported that it was Warm and Painful to Touch. On 20-JAN-2021, the spot on her arm grew to about the Size of a Baseball and continued to be painful and hot to touch. The spot on her arms has not changed from 20-JAN-2021 to today 21-JAN-2021 and reported that she developed a Warm Feeling on her Face and Extremely Cold Hands. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1568586
Sex: F
Age: 53
State: CA

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: really hot/hot to the touch; arm was really sore again; raised red; hurts; massive headache; arm was sore; A spontaneous report was received from a consumer concerning a 53 year old female patient who received Modern's COVID-19 vaccine (mRNA-1273) who experienced arm was sore/pain in arm, arm was really sore again/pain in arm, raised red/vaccination site erythema, really hot/ hot to the touch/vaccination site warmth, hurts/vaccination site pain, massive headache/headache. The patient's medical history and concomitant medication were not reported. On 15Jan2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 028L20A) in left arm for prophylaxis of COVID-19 infection. On 19Jan2021, the patient experienced arm was sore. On 26Jan2021, the patient arm was really sore again, raised red, really hot/ hot to the touch, hurts, massive headache. No Laboratory details provided. Advil was given as treatment for the events. Action taken with mRNA-1273 in response to the events was not reported. At the time of this report, the outcome of the event arm was sore is recovered on 21Jan2021. At the time of this report, the outcome of the event arm was really sore again, raised red, really hot/ hot to the touch, hurts, massive headache is unknown. The consumer assessed the event arm was sore, arm was really sore again, raised red, really hot/ hot to the touch, hurts, massive headache were not reported.

Other Meds:

Current Illness:

ID: 1568587
Sex: F
Age: 68
State: FL

Vax Date: 01/20/2021
Onset Date: 01/21/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; Joint pain; Headache; soreness in her arm injection site; A Spontaneous case report was received from a consumer who was a 68 year old female patient who has received first dose of Moderna COVID-19 Vaccine(mRNA-1273) on her right arm on 20-JAN-2021.She experienced chills,joint pain,headache and soreness in her arm. at injection site.No past medical history and treatment was provided.The outcome of the patient is unknown.

Other Meds:

Current Illness:

ID: 1568588
Sex: F
Age: 34
State: VA

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnancy) in a 34-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The patient's past medical history included Pregnancy (low birth weight) on 04-Sep-2018. Concurrent medical conditions included Allergy to antibiotic (Amoxicillin, Penicillin.). Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81) for Low birth weight baby, DOXYLAMINE SUCCINATE, PYRIDOXINE HYDROCHLORIDE (DICLEGIS) for Morning sickness, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 18-Jun-2020 and the estimated date of delivery was 01-Apr-2021. On 21-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the thirty-first week of the pregnancy. At the time of the report, EXPOSURE DURING PREGNANCY (Pregnancy) had resolved. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Sep-2020, Ultrasound scan: unknown (Inconclusive) Unknown. On 19-Nov-2020, Ultrasound scan: unknown (Inconclusive) Unknown. On 23-Dec-2020, Glucose tolerance test: unknown (Inconclusive) Unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. On 04-Sep-2018, patient had a previous pregnancy that ended with live, full-term birth and had the complication of low birth weight. The patient reports prior use of alcohol 1-2 drinks/week. Company Comment: This is a case of product exposure during pregnancy with no associated AEs for this female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.

Other Meds: PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]; ASPIRIN 81; DICLEGIS

Current Illness: Allergy to antibiotic (Amoxicillin, Penicillin.)

ID: 1568589
Sex: M
Age:
State: TX

Vax Date: 12/31/2020
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: diagnosed with COVID; A spontaneous report was received from a consumer concerning a patient who received Moderna's COVID-19 vaccine (mRNA-1273) and he got possitive with COVID-19. The patient's medical history was not provided. No relevant concomitant medications were reported. On 31-12-2020, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 for prophylaxis of COVID-19 infection. The patient told he only had symptoms for couple of days. The symptoms are not given by the patient. Laboratory details are not provided. The patient didn't take any medication. Action taken with mRNA-1273 in response to the events was not reported. The events are not resolved . At the time of this report, the outcome of the event was not resolved.

Other Meds:

Current Illness:

ID: 1568590
Sex: F
Age: 77
State: FL

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dark urine; Arm pain; A spontaneous report was received from a consumer (caregiver) concerning her mother, a 78-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced dark urine/chromaturia and arm pain/pain in extremity. The patient's medical history, as provided by the reporter, included allergy to sulfurs and lung cancer. Concomitant medications reported included bp medication, cholesterol medication and cancer pill. On 13 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) through unknown route of administration in the upper left arm for prophylaxis of COVID-19 infection. On 13 Jan 2021, the patient experienced dark urine and arm pain. Lab details were not provided by the reporter. Treatment for the events were unknown. Action taken with mRNA-1273 in response to the events were not reported. The outcome of the events dark urine and arm pain were unknown.

Other Meds:

Current Illness: Drug allergy (Medical history reported as allergies: sulfurs); Lung cancer (Medical history reported as lung cancer)

ID: 1568591
Sex: M
Age: 60
State: PA

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: feels cold; absolutely shivering; Sore Arm; A spontaneous report was received from a consumer concerning a 60 years old, male patient who developed Sore Arm/ Pain in extremity , absolutely shivering/ Chills , feels cold/ Nasopharyngitis. The patient's medical history was not provided. Additional suspected products included Metformin, Dertin, Omeprazole, Insulin, Aspirin, Vitamin D. The patient received their first of two planned doses of mRNA-1273 (Batch number not provided) on 20-Jan-2021. On 20-Jan-2021, approximately few hours prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number not provided) intramuscularly for prophylaxis of COVID-19 infection. Patient had a sore arm last night and today he is absolutely shivering, he has three blankets on and still feels cold. Treatment information was unknown. Action taken with mRNA-1273 in response to the event(s) was not provided. The outcome of the events were unknown.

Other Meds: METFORMIN; DERTIN; OMEPRAZOLE; INSULIN; ASPRIN; VITAMIN D [COLECALCIFEROL]

Current Illness:

ID: 1568592
Sex: F
Age: 40
State: AR

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Eyes were red; Raised from shoulder to elbow; Left arm was red; Itching; Lymph n odes on both side of her neck were swollen; Tired; several Asthma attacks; Arm was sore; A spontaneous report was received from a Reporter like HCP concerning a 40 Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events such as sore left arm, Tired, Reaction to the vaccine, very tired, several asthma attacks, swollen lymph nodes on both side of her neck, Red eyes, Red and raised left arm from shoulder to elbow, itching left arm from shoulder to elbow, extremely tired. The patient's medical history was not provided. No relevant concomitant medications were reported. On 15-01-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 batch no:027L20A intramuscularly in the Anatomical location for prophylaxis of COVID-19 infection. On 5th, 15th and 20th , The patient experienced the events such as sore left arm, Tired, Reaction to the vaccine, very tired, several asthma attacks, swollen lymph nodes on both side of her neck, Red eyes, Red and raised left arm from shoulder to elbow, itching left arm from shoulder to elbow, extremely tired. Laboratory details are not provided. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The events are still not resolved.

Other Meds: BUSPAR; KLONOPIN; VITAMIN B12 NOS; VITAMIN D [VITAMIN D NOS]

Current Illness:

ID: 1568593
Sex: U
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Redness; Warm injection site; A spontaneous report was received from a Physician concerning his patient, of unknown age and sex who developed redness/erythema, warm injection site/vaccination site warmth. The patient's medical history was not provided. Concomitant product use was not provided by the reporter. The patients received their first of two planned doses of mRNA-1273 (Batch number: unknown) on unknown date in unknown injection site for prophylaxis of COVID-19 infection. The patients developed redness, very warm injection site reaction after 8-10 days of receiving 1st shot of Moderna COVID vaccine. Treatment of the event was not provided. Action taken with mRNA-1273 in response to the event(s) was not provided/unknown. The outcome of the event(s) redness and warm injection site was not reported.

Other Meds:

Current Illness:

ID: 1568594
Sex: F
Age:
State: ID

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: throat had a tickle in it, felt funny; A spontaneous report was received from a healthcare professional (Pharmacist) concerning a female patient who was in her late 30's, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced tickle in her throat(felt funny). The patient's medical history, as provided by the reporter, included exercise-induced asthma, but does not take any medications for it (hadn't had to use a rescue inhaler for almost a year). On 15 Jan 2021, approximately five to ten minutes prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) for prophylaxis of COVID-19 infection. On observing the event she was given two puffs of albuterol inhaler and felt better. After 15 minutes her throat was doing it again. They gave her oral Benadryl 25mg. The staff took her to the emergency room and gave low dose oral prednisone for three days and a single oral dose of famotidine. Action taken with mRNA-1273 in response to the events was not reported. The events, tickling in throat were considered resolved after two days. The reporter considered it as a anxiety-type reaction as she came to the vaccination site alone.

Other Meds:

Current Illness:

ID: 1568595
Sex: M
Age: 62
State: TX

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Being confused; having cold chills; fever; nausea; Lot of headache; Arm was hurting; I couldn't sleep all night; sweating a lot; Fatigue; A spontaneous report was received from a 62-years-old male patient concerning himself who received Modern's COVID-19 vaccine (mRNA-1273) and experienced arm hurting, couldn?t sleep at all night, sweating a lot, having cold chills, suppose had a fever, nausea , chills and fatigue, being confused and having lot of headaches. The patient's medical history was provided. as diabetes. No relevant concomitant medications reported. On 19 Jan 2021, prior to the onset of the events, the patient received the first dose of two planned doses of mRNA-1273 (lot/batch:011L20A) via unknown route of administration and unknown anatomical location for prophylaxis of COVID-19 infection. On 19 Jan 2021, the patient developed arm hurting, couldn?t sleep at all night, sweating a lot, having cold chills. On 20 Jan 2021, patient experienced suppose had a fever, nausea, chills and fatigue, being confused and having lot of headaches. Treatment information provided was Tylenol (acetaminophen). Action taken with mRNA-1273 in response to the events was not reported. At the time of the report, the outcome of events arm hurting, couldn?t sleep at all night, sweating a lot, having cold chills, suppose had a fever, nausea , chills and fatigue, being confused was unknown and having lot of headache was considered recovered.

Other Meds:

Current Illness: Diabetes

ID: 1568596
Sex: F
Age:
State: FL

Vax Date: 01/09/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: lethargic; hot; slight fever, up by 1 degree; chilled; the arm started to itch like crazy; it was red; swollen; hard; A spontaneous report was received from a reporter concerning a 71-year-old, female patient, participating in the who received Moderna's COVID-19 vaccine (mRNA-1273) Emergency Use Program who and experienced lethargy, chills, fever, vaccination site pruritus, vaccination site erythema, vaccination site swelling, vaccination site warmth, vaccination site induration. The patient's medical history, was not provided by the reporter. There were no Concomitant medications reported. The patient received their first of two planned dose of mRNA-1273 on 09jan2021. On 09jan2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 039K2014) in the right arm for prophylaxis of COVID-19 infection. Initially after receiving mRNA-1273, the patient experienced lethargy, chills, fever up by 1 degree. Action taken with mRNA-1273 in response to the events was not reported. The events, lethargy, chills, fever were considered resolved. The reporter did not provide an assessment for the .events lethargy, chills, fever, vaccination site pruritus, vaccination site erythema, vaccination site swelling, vaccination site warmth, vaccination site induration.

Other Meds:

Current Illness:

ID: 1568597
Sex: F
Age: 34
State: TX

Vax Date: 12/31/2020
Onset Date: 12/31/2020
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fatigue; Achy; Pregnant; This spontaneous prospective pregnancy case was reported by a patient and describes the occurrence of FATIGUE (Fatigue), MYALGIA (Achy) and MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K20A and 032L20A) for COVID-19 vaccination. Concurrent medical conditions included Latex allergy. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication. On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 15-Jun-2021. On 31-Dec-2020, the patient experienced FATIGUE (Fatigue), MYALGIA (Achy) and MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). The patient was treated with PARACETAMOL (TYLENOL) for Adverse reaction, at a dose of 1 dosage form. On 31-Dec-2020, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved. At the time of the report, FATIGUE (Fatigue) and MYALGIA (Achy) outcome was unknown. The patient had established prenatal care. Number of fetuses was reported as 1.

Other Meds: PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]

Current Illness: Latex allergy

ID: 1568598
Sex: F
Age: 58
State: KY

Vax Date: 01/12/2021
Onset Date: 01/13/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: body aches; Severe Arm Pain; could not lift her arm; Could not shower for 2 days; Could not eat for 2 days; caused a flare up of auto immune disease; Still not feeling normal; severe headaches; A spontaneous report was received from a consumer concerning a 58-female patient, who received Moderna COVID-19 vaccine (mRNA-1273) and experienced severe headache , body aches, severe arm pain so that she could not lift her arm and it caused a flare up of auto immune disease and could not shower or eat for 2 days. The patient's medical history was not provided. Relevant concomitant medications include Dupixent and Prednisone was reported. On 12-jan-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273(lot number : 039K20A) intramuscularly on left upper arm for the prophylaxis of COVID-19 infection. On 13-jan-2021, the patient experienced severe headache , body aches, severe arm pain so that she could not lift her arm and it caused a flare up of auto immune disease and could not shower or eat for 2 days. No treatment information was provided . Action taken with mRNA-1273 in response to the events was not reported. At the time of report, the outcome of the events severe headache , body aches, severe arm pain so that she could not lift her arm and it caused a flare up of auto immune disease and could not shower or eat for 2 days was unknown.

Other Meds: DUPIXENT; PREDNISONE

Current Illness:

ID: 1568599
Sex: F
Age:
State:

Vax Date: 01/07/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Redness at the injection site; Itchiness on her arm at the injection site; Pain in wrist on the same arm; A spontaneous case report (united states) was received from a consumer, concerning female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) experienced redness and itchiness on her arm at the injection site and pain in wrist on the same arm. The patient's medical history not provided by the reporter. Concomitant medications were not reported. On unknown date, patient received their first of two planned doses of mRNA-1273 (Lot/Batch: unknown) for prophylaxis of COVID-19 infection. On unknown date, patient experienced redness and itchiness on her arm at the injection site and pain in wrist on the same arm. Treatment information was not provided Action taken with mRNA-1273 in response to the event was not reported. The outcome of event experienced for redness and itchiness on her arm at the injection site and Pain in wrist was unknown.

Other Meds:

Current Illness:

ID: 1568600
Sex: M
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fatigue; Headache; Chills; Mild fever; A spontaneous report was received from 83 years old female patient of unknown age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fatigue, headache, chills and mild fever. Medical history was not reported. Concomitant medication was not reported. On an unknown date, prior to the onset of the events fatigue, headache, chills and mild fever, the patient received their first of two planned doses of mRNA-1273 (lot/batch: O11L01A) via unknown route in unknown anatomical location for prophylaxis of COVID-19 infection. On an unknown date, the patient experienced events fatigue, headache, chills and mild fever. Laboratory details was not provided. Treatment medication included acetaminophen and aspirin at an unknown dose and frequency via an unknown route for fever. Action taken with mRNA-1273 in response to the events fatigue, headache, chills and mild fever was not provided. The outcome of the events fatigue, headache, chills and mild fever was not provided and the outcome of the event mild fever was recovered on an unknown date. The reporter did not provide the assessment of the events fatigue, headache, chills and mild fever to study drug.

Other Meds:

Current Illness:

ID: 1568601
Sex: F
Age: 79
State: MT

Vax Date: 01/13/2021
Onset Date: 01/15/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Redness on the shoulder from the injection side; Swollen shoulder; A spontaneous report was received from the consumer,79 years old female has developed redness on the shoulder from the injection side, as well as the swollen shoulder from her 1st dose of Moderna.Patients medical history was unknown. Patients concomitant medication was unknown.S he has received COVID-19 Vaccine on January 13, 2021.She wanted to know whether it will impact her ability to get her 2nd dose of COVID-19 Vaccine.The event has not recovered.

Other Meds:

Current Illness:

ID: 1568602
Sex: F
Age: 65
State: FL

Vax Date: 01/11/2021
Onset Date: 01/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arm started itching at vaccination site; became red at the vaccination site; swollen at the vaccination site; A spontaneous report was received from a consumer (patient) concerning an 65-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced arm started itching at vaccination site, became red at the vaccination site and swollen at the vaccination site. No medical history was provided. No relevant concomitant medications were reported. On 11-Jan-2021, 8 days prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 026L20A) intramuscularly for prophylaxis of COVID-19 infection. On 19-Jan-2021, the patient experienced arm started itching at vaccination site, became red at the vaccination site and swollen at the vaccination site. Treatment information included patient took Hydrocortisone, Benadryl. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the events, arm started itching at vaccination site, became red at the vaccination site and swollen at the vaccination site were unknown.

Other Meds:

Current Illness:

ID: 1568603
Sex: F
Age: 77
State: LA

Vax Date: 01/07/2021
Onset Date: 01/17/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Red splotch at injection site. Bigger than a 50 cent piece and not perfectly round, has some; Felt a little Warm at Injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Red splotch at injection site. Bigger than a 50 cent piece and not perfectly round, has some) and VACCINATION SITE WARMTH (Felt a little Warm at Injection site) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L208) for COVID-19 vaccination. No Medical History information was reported. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red splotch at injection site. Bigger than a 50 cent piece and not perfectly round, has some) and VACCINATION SITE WARMTH (Felt a little Warm at Injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Red splotch at injection site. Bigger than a 50 cent piece and not perfectly round, has some) and VACCINATION SITE WARMTH (Felt a little Warm at Injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1568604
Sex: F
Age: 79
State: AL

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Soreness on the Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness on the Injection Site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness on the Injection Site). At the time of the report, VACCINATION SITE PAIN (Soreness on the Injection Site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1568605
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: a little bit of a rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (a little bit of a rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced VACCINATION SITE RASH (a little bit of a rash). At the time of the report, VACCINATION SITE RASH (a little bit of a rash) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1568606
Sex: F
Age:
State:

Vax Date: 01/18/2021
Onset Date: 01/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Not feeling good; headache; chills; kind of fever; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling good), HEADACHE (headache), CHILLS (chills) and PYREXIA (kind of fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced MALAISE (Not feeling good), HEADACHE (headache), CHILLS (chills) and PYREXIA (kind of fever). On 21-Jan-2021, MALAISE (Not feeling good), HEADACHE (headache), CHILLS (chills) and PYREXIA (kind of fever) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1568607
Sex: F
Age: 29
State: CA

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 29-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The patient's past medical history included Pregnancy (Live, full-term birth High blood pressure towards the end) on 24-Jun-2018, Blood pressure high and Alcohol use (3-5 times a week) on 28-Aug-2020. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) and VITAMINS NOS for an unknown indication. On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 28-Jul-2020 and the estimated date of delivery was 12-May-2021. On 01-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the twenty-seventh week of the pregnancy. On 01-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Aug-2020, Pregnancy test: positive (Positive) Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Concomitant medications were not provided. Lab tests include ULTRASOUND(normal), GLUCOSE TESTING(normal), GENETIC TESTING(normal) on an unknown date . No treatment information was provided.

Other Meds: BABY ASPIRIN; VITAMINS NOS

Current Illness:

ID: 1568608
Sex: F
Age: 31
State: MA

Vax Date: 01/03/2021
Onset Date: 01/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 31-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 028L20A) for COVID-19 vaccination. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication. On 03-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 21-Aug-2020 and the estimated date of delivery was 27-May-2021. On 03-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the nineteenth week of the pregnancy. On 03-Jan-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Sep-2020, Pregnancy test: positive (Positive) positive. On 15-Sep-2020, Ultrasound foetal: normal (normal) normal. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. The date of positive pregnancy test was 15-Sep-2020. The patient has an established prenatal care. No treatment medications provided by the reporter.

Other Meds: PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]

Current Illness:

ID: 1568609
Sex: F
Age: 27
State: CA

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Heart rate higher than it normally is; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Heart rate higher than it normally is) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Anaphylaxis. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced HEART RATE INCREASED (Heart rate higher than it normally is). On 17-Jan-2021, HEART RATE INCREASED (Heart rate higher than it normally is) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered HEART RATE INCREASED (Heart rate higher than it normally is) to be possibly related. Treatment information not provided.

Other Meds:

Current Illness:

ID: 1568610
Sex: F
Age:
State: ND

Vax Date: 01/13/2021
Onset Date: 01/21/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore arm; super itchy and breaking out with hives; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of INJECTION SITE PAIN (sore arm) and URTICARIA (super itchy and breaking out with hives) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 13-Jan-2021 at 6:20 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced URTICARIA (super itchy and breaking out with hives). On an unknown date, the patient experienced INJECTION SITE PAIN (sore arm). At the time of the report, INJECTION SITE PAIN (sore arm) and URTICARIA (super itchy and breaking out with hives) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered INJECTION SITE PAIN (sore arm) and URTICARIA (super itchy and breaking out with hives) to be possibly related. Patient states she has not been exposed to any new food, soap, or solutions. Treatment information not provided.

Other Meds:

Current Illness:

ID: 1568611
Sex: F
Age: 59
State: NJ

Vax Date: 01/11/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain in the right arm muscle that takes whole arm; Weakness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the right arm muscle that takes whole arm) and MUSCULAR WEAKNESS (Weakness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. No Medical History information was reported. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in the right arm muscle that takes whole arm) and MUSCULAR WEAKNESS (Weakness). At the time of the report, PAIN IN EXTREMITY (Pain in the right arm muscle that takes whole arm) and MUSCULAR WEAKNESS (Weakness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient received Tylenol, Bediatil, warm and hot compress for treatment. No concomitant medication reported.

Other Meds:

Current Illness:

ID: 1568612
Sex: F
Age:
State: CO

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain in Ribcage; Pain (Injection Site); This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL CHEST PAIN (Pain in Ribcage) and VACCINATION SITE PAIN (Pain (Injection Site)) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Hypertension in December 2015, Flutter atrial in August 2017 and Subdural hematoma removal in September 2015. Concurrent medical conditions included Drug allergy (Norco (Tetracycline, Hydrocodone, Bitartrate, Acetaminophen)) and Drug allergy (Achromycin (Tetracycline HCL)). Concomitant products included CEFALEXIN MONOHYDRATE (LEXIPRON) for Depression, LOSARTAN for Hypertension, LATANOPROST for Prevent Glaucoma, APIXABAN (ELIQUIS) for blood thinner, ATORVASTATIN CALCIUM (LIPITOR) for stroke prevention. On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced MUSCULOSKELETAL CHEST PAIN (Pain in Ribcage) and VACCINATION SITE PAIN (Pain (Injection Site)). At the time of the report, MUSCULOSKELETAL CHEST PAIN (Pain in Ribcage) and VACCINATION SITE PAIN (Pain (Injection Site)) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information not provided. Most recent FOLLOW-UP information incorporated above includes: On 12-Apr-2021: No specific follow-up information recorded. On 20-Apr-2021: No specific follow-up information recorded.

Other Meds: ELIQUIS; LEXIPRON; LOSARTAN; LIPITOR; LATANOPROST

Current Illness:

Total 2021 VAERS Injuries: 704,237

Page last modified: 03 October 2021 5:28pm